statistical analysis software jmp pro version 13 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
statistical analysis software jmp pro version 13
Statistical Analysis Software Jmp Pro Version 13, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+analysis+software+version+13/jmp+software+package/pm37757763-65-6-10
Average 90 stars, based on 1 article reviews
Statistical Analysis Software Jmp Pro Version 13, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/statistical+analysis+software+version+13/jmp+software+package/pm37757763-65-6-10
Average 90 stars, based on 1 article reviews
statistical analysis software jmp pro version 13 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Phenolic Content, Antioxidant Capacity and In Vitro Glycemic Index of Traditional Noodle (Erişte) High in Plant‐Based Protein and β ‐Glucan Content Article Snippet: All statistical analysis was performed with software Article Title: The Missing Link: Hepatitis C Linkage to Care through a Public Sexual Health Clinic Article Snippet: Amirtha Dileepan, MD, MSPH1,2,3; Lucy Alderton, MPH1; Oluyomi Obafemi, MD, MPH1,3; Sarah E. Rowan, MD1,4; Karen A. Wendel, MD1,3,4 1Public Health Institute at Denver Health, Denver, CO. 2Department of Preventive Medicine, University of Colorado School of Medicine, Aurora, CO. 3Denver Prevention Training Center, Division of HIV/STI Prevention, Public Health Institute at Denver Health, Denver, CO. 4Division of Infectious Disease, Department of Medicine, University of Colorado School of Medicine, Aurora, CO Corresponding author: Amirtha Dileepan, MD, MSPH; address: 2240 Creekside Dr. Longmont, CO, 80504; fax number: 423-503-8674; telephone number: 423-503-8674; email: amirtha.dileepan@gmail.com; There are no conflicts of interest to disclose.. This study was supported by the Denver Prevention Training Center, Division of HIV/STI Prevention, Public Health Institute at Denver Health and by University of Colorado School of Medicine.. Sexually Transmitted Diseases, Publish Ahead of Print DOI: 10.1097/OLQ.0000000000002114 AC CE PT ED Copyright © 2024 by the American Sexually Transmitted Diseases Association. Article Title: Efficacy of a novel method: VaSodilator injection via the over-the-wire lumen during drug-coated balloon dilatation to prevent the slow-flow phenomenon in treatment of femoropopliteal lesions. Article Snippet: In drug-coated balloon (DCB) angioplasty for femoropopliteal lesions, there are adverse effects of drug embolization on downstream non-target organs following the slow-flow phenomenon.. We devised a novel method, known as VaSodilator injection via the over-the-wire lumen during DCB dilatation to prevent the slow-flow phenomenon in treatment of femoropopliteal lesions (V.S.O.P.), and evaluated its efficacy and safety.. This single-center, retrospective, observational study analyzed 196 femoropopliteal lesions treated with IN.PACT Admiral between April 2018 and July 2023. Article Title: Induction hepatic arterial infusion chemotherapy followed by surgery for hepatocellular carcinoma with massive portal vein tumor thrombosis: a case series of 20 patients. Article Snippet: Statistical analysis was performed using Software:Article Title: The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension Article Snippet: .. Statistical analysis was performed using Article Title: Repeat Bronchoscopies Are Poorly Predictive of Outcomes Following Inhalation Injury. Article Snippet: 1Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA; 2Department of Anesthesiology, Brooke Army Medical Center, Fort Sam Houston, TX 78234, USA; 3Department of Anesthesiology, University of Colorado School of Medicine, Aurora, CO 80045, USA; 4Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO 80045, USA; 5Center for Combat and Battlefield (COMBAT) Research, University of Colorado School of Medicine, Aurora, CO 80045, USA; 6Department of Trauma, Brooke Army Medical Center, Fort Sam Houston, TX 78234, USA Author Contributions: Matthew Smith (Conceptualization [equal], Formal analysis, Methodology, Writing—original draft, Writing—review & editing [lead]), Michael D. April (Writing—review & editing [supporting]), Steven G. Schauer (Writing—review & editing [supporting]), and Julie Rizzo (Conceptualization [equal], Formal analysis, Investigation [lead], Methodology [equal], Supervision [lead], Writing—review & editing [supporting]) Funding: No relevant funding was received for this work.. Conflict of Interest Statement: The views expressed herein are those of the author(s) and do not necessarily reflect the official policy or position of the Defense Health Agency, Brooke Army Medical Center, the Department of Defense, nor any agencies under the US Government.. No authors have any individual relevant disclosures. Article Title: Trajectory of bodyweight and skeletal muscle mass in patients treated with nintedanib for idiopathic pulmonary fibrosis Article Snippet: .. The statistical analysis was conducted using |